Citation: A. Burnett et M. Peel, Asylum seekers and refugees in Britain - Health needs of asylum seekers and refugees, BR MED J, 322(7285), 2001, pp. 544-547
Citation: A. Burnett et M. Peel, Asylum seekers and refugees in Britain - What brings asylum seekers to theUnited Kingdom?, BR MED J, 322(7284), 2001, pp. 485-488
Citation: A. Burnett et M. Peel, Asylum seekers and refugees in Britain - The health of survivors of torture and organised violence, BR MED J, 322(7286), 2001, pp. 606-609
Authors:
Hilfinger, MF
Mullins, HT
Burnett, A
Kirby, ME
Citation: Mf. Hilfinger et al., A 2500 year sediment record from Fayetteville Green Lake, New York: evidence for anthropogenic impacts and historic isotope shift, J PALEOLIMN, 26(3), 2001, pp. 293-305
Authors:
Basson, R
Berman, J
Burnett, A
Derogatis, L
Ferguson, D
Fourcroy, J
Goldstein, I
Graziottin, A
Heiman, J
Laan, E
Leiblum, S
Padma-Nathan, K
Rosen, R
Segraves, K
Segraves, RT
Shabsigh, R
Sipski, M
Wagner, G
Whipple, B
Citation: R. Basson et al., Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications, J SEX MAR T, 27(2), 2001, pp. 83-94
Authors:
Safra, T
Groshen, S
Jeffers, S
Tsao-Wei, DD
Zhou, LY
Muderspach, L
Roman, L
Morrow, CP
Burnett, A
Muggia, FM
Citation: T. Safra et al., Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin - Analysis of toxicities and predictors of outcome, CANCER, 91(1), 2001, pp. 90-100
Authors:
Safra, T
Groshen, S
Jeffers, S
Tsao-Wei, DD
Zhou, LY
Muderspach, L
Roman, L
Morrow, CP
Burnett, A
Muggia, FM
Citation: T. Safra et al., Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin - Analysis of toxicities and predictors of outcome, CANC CYTOP, 91(1), 2001, pp. 90-100
Authors:
Iqbal, S
Grimwade, D
Chase, A
Goldstone, A
Burnett, A
Goldman, JM
Swirsky, D
Citation: S. Iqbal et al., Identification of PML/RAR alpha rearrangements in suspected acute promyelocytic leukemia using fluorescence in situ hybridization of bone marrow smears: a comparison with cytogenetics and RT-PCR in MRC ATRA trial patients, LEUKEMIA, 14(5), 2000, pp. 950-953
Authors:
Basson, R
Berman, J
Burnett, A
Derogatis, L
Ferguson, D
Fourcroy, J
Goldstein, I
Graziottin, A
Heiman, J
Laan, E
Leiblum, S
Padma-Nathan, H
Rosen, R
Segraves, K
Segraves, RT
Shabsigh, R
Sipski, M
Wagner, G
Whipple, B
Citation: R. Basson et al., Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications, J UROL, 163(3), 2000, pp. 888-893
Authors:
Marroum, PJ
Uppoor, RS
Parmelee, T
Ajayi, F
Burnett, A
Yuan, R
Svadjian, R
Lesko, LJ
Balian, JD
Citation: Pj. Marroum et al., In vivo drug-drug interaction studies - A survey of all new molecular entities approved from 1987 to 1997, CLIN PHARM, 68(3), 2000, pp. 280-285
Authors:
Hehlmann, R
Heimpel, H
Hasford, J
Allan, N
Burnett, A
Shepherd, P
Oberg, G
Simonsson, B
Stromberg, U
Alison, R
Clarke, M
Evans, V
Godwin, J
MacKinnon, E
Richards, S
Citation: R. Hehlmann et al., Hydroxyurea versus busulphan for chronic myeloid leukaemia: an individual patient data meta-analysis of three randomized trials, BR J HAEM, 110(3), 2000, pp. 573-576
Authors:
Burnett, A
Baggaley, R
Ndovi-MacMillan, M
Sulwe, J
Hang'omba, B
Bennett, J
Citation: A. Burnett et al., Caring for people with HIV in Zambia: are traditional healers and formal health workers willing to work together?, AIDS CARE, 11(4), 1999, pp. 481-491
Authors:
Allford, S
Grimwade, D
Langabeer, S
Duprez, E
Saurin, A
Chatters, S
Walker, H
Roberts, P
Rogers, J
Bain, B
Patterson, K
McKernan, A
Freemont, P
Solomon, E
Burnett, A
Goldstone, A
Linch, D
Citation: S. Allford et al., Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RAR alpha rearrangement in newly diagnosed AML, BR J HAEM, 105(1), 1999, pp. 198-207
Authors:
Gray, R
Clarke, M
Peto, R
Richards, S
Wheatley, K
Masera, G
Allan, N
Montserrat, E
Maclennan, I
Burnett, A
Henry-Amar, M
Citation: R. Gray et al., Systematic overviews of randomised controlled trials in the treatment of colorectal cancer, leukaemia, myeloma and lymphoma, BIOM HLTH R, 24, 1998, pp. 30-33